ATOA - Otto,M.; Zirk,A.; Cepek,L.; Irle,E.; Pergande,G.; Ellers-Lenz,B.; Windl,O.; Kretzschmar,H.A.; Prange,H.; Mollenhauer,B. - Flupirtine and Dapsone on Cognitive Function in Patients with CJD - International Conference - Prion 2005: Between fundamentals and society's needs - 19.10.-21.10.2005, Congress Center Düsseldorf - Poster Session: Human prions, risk of blood products, and therapy HUMAN-24
AQNK - Otto,M.; Cepek,L.; Ratzka,P.; Doehlinger,S.; Boekhoff,I.; Wiltfang,J.; Irle,E.; Pergande,G.; Ellers-Lenz,B.; Windl,O.; Kretzschmar,H.A.; Poser,S.; Prange,H. - Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study. - Neurology 2004 Mar 9; 62(5): 714-8
AJJK - Perovic,S.; Bohm,M.; Meesters,E.; Meinhardt,A.; Pergande,G.; Müller,W.E.G. - Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases. - Mechanisms of Ageing and Development 1998 Mar 16; 101(1-2): 1-19
AJJL - Perovic,S.; Schröder,H.C.; Pergande,G.; Ushijima,H.; Müller,W.E.G. - Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126) - Experimental Neurology 1997 Oct; 147(2): 518-24
AJJM - Perovic,S.; Pergande,G.; Ushijima,H.; Kelve,M.; Forrest,J.; Müller,W.E.G. - Flupirtine partially prevents neuronal injury induced by prion protein fragment and lead acetate - Neurodegeneration. A Journal for neurodegenerative Disorders, Neuroprotection, and Neuroregeneration 1995 Dec; 4(4): 369-74